Abstract:Background: Individuals with pathogenic germline variants in DNA mismatch repair (MMR) genes are at increased risk of developing colorectal, endometrial and other cancers (Lynch syndrome, LS). While previous studies have extensively described cancer risks in LS, cancer risks in individuals from families without detectable MMR gene defects despite MMR deficiency (Lynch-like syndrome, LLS), and in individuals from families fulfilling the Amsterdam-II criteria without any signs of MMR deficiency (familial colorectal cancer type X, FCCX) are less well studied. The aim of this prospective study was to characterise the risk for different cancer types in LS, LLS, and FCCX, and to compare these with the cancer risks in the general population. Methods: Data was taken from the registry of the German Consortium for Familial Intestinal Cancer, where individuals were followed up prospectively within the framework of an intensified surveillance programme at recommended annual examination intervals. A total of 1120 LS, 594 LLS, and 116 FCCX individuals were analysed. From this total sample, eight different cohorts were defined, in which age-dependent cumulative risks and standardised incidence ratios were calculated regarding the first incident occurrence of any, colorectal, stomach, small bowel, urothelial, female breast, ovarian, and endometrial cancer, separately for LS, LLS, and FCCX. Results: The number of individuals at risk for first incident cancer ranged from 322 to 1102 in LS, 120 to 586 in LLS, and 40 to 116 in FCCX, depending on the cancer type of interest. For most cancer types, higher risks were observed in LS compared to LLS, FCCX, and the general population. Risks for any, colorectal, stomach, urothelial, and endometrial cancer were significantly higher in LLS compared to the general population. No significantly increased risks could be detected in FCCX compared to LLS patients, and the general population. Colorectal and endometrial cancer risks tended to be higher in LLS than in FCCX. Conclusions: The characterisation of cancer risks in patients with LLS and FCCX is important to develop appropriate surveillance programmes for these specific intermediate risk groups. Larger prospective studies are needed to obtain more precise risk estimates.

Cancer Diagnosis in First-Degree Relatives and Non-Small Cell Lung Cancer Risk: Results from a Multi-Centre Case–control Study in Europe

Increased risk of cancer among relatives of patients with lung cancer in China

Combined Effects of Cigarette Smoking, Gene Polymorphisms and Methylations of Tumor Suppressor Genes on Non Small Cell Lung Cancer: a Hospital-Based Case-Control Study in China

Cross Cancer Genomic Investigation of Inflammation Pathway for Five Common Cancers: Lung, Ovary, Prostate, Breast, and Colorectal Cancer.

Genome-wide Association Study of Familial Lung Cancer.

Data from Cumulative Effect of Multiple Loci on Genetic Susceptibility to Familial Lung Cancer

Influence of Common Genetic Variation on Lung Cancer Risk: Meta-Analysis of 14 900 Cases and 29 485 Controls

Clinical implications of the family history in patients with lung cancer: a systematic review of the literature and a new cross-sectional/prospective study design (FAHIC: lung)

Systematic Review of the Relationship Between Family History of Malignant Tumor and Lung Cancer Risk

A Linear Relationship between the Number of Cancers among First-degree Relatives and the Risk of Multiple Primary Cancers

Familial aggregation of common sequence variants on 15q24-25.1 in lung cancer.

Germline EGFR mutations and familial lung cancer

Family history of cancer and lung cancer: Utility of big data and artificial intelligence for exploring the role of genetic risk

High Risk Occupational Exposure And Family History Were Risk Factors In Young Lung Cancer In Chinese

Potential genetic modifiers for somatic EGFR mutation in lung cancer: a meta-analysis and literature review

Supplementary Tables 1-7 from Cumulative Effect of Multiple Loci on Genetic Susceptibility to Familial Lung Cancer

Quantification of Familial Risk of Nasopharyngeal Carcinoma in A High-Incidence Area

Cancer risks in Lynch syndrome, Lynch-like syndrome, and familial colorectal cancer type X: a prospective cohort study

The Personalized Inherited Signature Predisposing to Non-Small-Cell Lung Cancer in Non-Smokers

Family history of esophageal cancer increases the risk of esophageal squamous cell carcinoma

The impact of family cancer history on tumor metabolism and prognosis in patients with non-small cell lung cancer